We found that components of the novel NOX2/Egr-1/Fyn pathway were also commonly up-regulated in EGFR-expressing patient GBM patient samples (Figure 5A) and cell line models (Figure 5B and 5C), where they remained dependent on p47phox (Figure 5I). The gene discussed is EGFR; the disease is glioblastoma.